Normal and malignant cells exhibit differential responses to calcium electroporation

Cancer Research

Volumn 77, Issue 16, 2017, Pages 4389-4401

  Frandsen, Stine K ^a   Krüger, Mie B ^a   Mangalanathan, Uma M ^a   Tramm, Trine ^b   Mahmood, Faisal ^a   Novak, Ivana ^a   Gehl, Julie ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM;

ANIMAL; CELL DIFFERENTIATION; ELECTROPORATION; FEMALE; HUMAN; MALE; METABOLISM; MOUSE; NECROSIS; NEOPLASMS; PATHOLOGY; PHYSIOLOGY; PROCEDURES; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; CALCIUM; CELL DIFFERENTIATION; CELL LINE, TUMOR; ELECTROPORATION; FEMALE; HETEROGRAFTS; HUMANS; MALE; MICE; NECROSIS; NEOPLASMS;

EID: 85025815419     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-16-1611     Document Type: Article

References (50)

1. Frandsen SK, Gissel H, Hojman P, Tramm T, Eriksen J, Gehl J. Direct therapeutic applications of calcium electroporation to effectively induce tumor necrosis. Cancer Res 2012;72:1336–41.
2. Gehl J, Skovsgaard T, Mir LM. Enhancement of cytotoxicity by electro-permeabilization: an improved method for screening drugs. Anticancer Drugs 1998;9:319–25.
3. Jaroszeski MJ, Dang V, Pottinger C, Hickey J, Gilbert R, Heller R. Toxicity of anticancer agents mediated by electroporation in vitro. Anticancer Drugs 2000;11:201–8.
4. Orlowski S, Belehradek J, Paoletti C, Mir LM. Transient electropermeabi-lization of cells in culture - increase of the cyto-toxicity of anticancer drugs. Biochem Pharmacol 1988;37:4727–33.
5. Sersa G, Cemazar M, Miklavcic D. Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum(II) in mice. Cancer Res 1995;55:3450–55.
6. Vasquez JL, Ibsen P, Lindberg H, Gehl J. In vitro and in vivo experiments on electrochemotherapy for bladder cancer. J Urol 2015;193:1009–15.
7. Hansen EL, Sozer EB, Romeo S, Frandsen SK, Vernier PT, Gehl J. Dose-dependent ATP depletion and cancer cell death following calcium electroporation, relative effect of calcium concentration and electric field strength. PLoS One 2015;10:e0122973.
8. NICE Guidance. Electrochemotherapy for metastases in the skin from tumours of non-skin origin (IPG446); 2013. Available from: http://www.nice.org.uk/guidance/IPG446
9. Belehradek M, Domenge C, Luboinski B, Orlowski S, Belehradek J Jr, Mir LM. Electrochemotherapy, a new antitumor treatment. First clinical phase I-II trial. Cancer 1993;72:3694–700.
10. Heller R, Jaroszeski MJ, Reintgen DS, Puleo CA, DeConti RC, Gilbert RA, et al. Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin. Cancer 1998;83:148–57.
11. Marty M, Sersa G, Garbay JR, Gehl J, Collins CG, Snoj M, et al. Electrochemotherapy - An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. EJC Supplements 2006;4:3–13.
12. Matthiessen LW, Chalmers RL, Sainsbury DC, Veeramani S, Kessell G, Humphreys AC, et al. Management of cutaneous metastases using electrochemotherapy. Acta Oncol 2011;50:621–9.
13. Frandsen SK, Gissel H, Hojman P, Eriksen J, Gehl J. Calcium electroporation in three cell lines: a comparison of bleomycin and calcium, calcium compounds, and pulsing conditions. Biochim Biophys Acta 2014;1840: 1204–8.
14. Berridge MJ, Bootman MD, Roderick HL. Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol 2003;4:517–29.
15. Zhivotovsky B, Orrenius S. Calcium and cell death mechanisms: a perspective from the cell death community. Cell Calcium 2011;50:211–21.
16. Guerini D, Garcia-Martin E, Zecca A, Guidi F, Carafoli E. The calcium pump of the plasma membrane: membrane targeting, calcium binding sites, tissue-specific isoform expression. Acta Physiol Scand Suppl 1998;643: 265–73.
17. Brini M, Carafoli E. Calcium signalling: a historical account, recent developments and future perspectives. Cell Mol Life Sci 2000;57:354–70.
18. Clapham DE. Calcium signaling. Cell 2007;131:1047–58.
19. Brini M, Cali T, Ottolini D, Carafoli E. The plasma membrane calcium pump in health and disease. FEBS J 2013;280:5385–97.
20. Aung CS, Kruger WA, Poronnik P, Roberts-Thomson SJ, Monteith GR. Plasma membrane Ca2þ-ATPase expression during colon cancer cell line differentiation. Biochem Biophys Res Commun 2007;355:932–6.
21. Ribiczey P, Tordai A, Andrikovics H, Filoteo AG, Penniston JT, Enouf J, et al. Isoform-specific up-regulation of plasma membrane Ca2þATPase expression during colon and gastric cancer cell differentiation. Cell Calcium 2007;42:590–605.
22. Frandsen SK, Gibot L, Madi M, Gehl J, Rols MP. Calcium electroporation: evidence for differential effects in normal and malignant cell lines, evaluated in a 3D spheroid model. PLoS One 2015;10:e0144028.
23. Gjetting T, Arildsen NS, Christensen CL, Poulsen TT, Roth JA, Handlos VN, et al. In vitro and in vivo effects of polyethylene glycol (PEG)-modified lipid in DOTAP/cholesterol-mediated gene transfection. Int J Nanomedicine 2010;5:371–83.
24. Herbsleb M, Birkenkamp-Demtroder K, Thykjaer T, Wiuf C, Hein AM, Orntoft TF, et al. Increased cell motility and invasion upon knockdown of lipolysis stimulated lipoprotein receptor (LSR) in SW780 bladder cancer cells. BMC Med Genomics 2008;1:31.
25. Hojman P, Spanggaard I, Olsen CH, Gehl J, Gissel H. Calcium electro-transfer for termination of transgene expression in muscle. Hum Gene Ther 2011;22:753–60.
26. Pavselj N, Preat V, Miklavcic D. A numerical model of skin electropermea-bilization based on in vivo experiments. Ann Biomed Eng 2007;35: 2138–44.
27. Pliquett U, Langer R, Weaver JC. Changes in the passive electrical properties of human stratum corneum due to electroporation. Biochim Biophys Acta 1995;1239:111–21.
28. Grimnes S, Martinsen ØG. Bioimpedance and bioelectricity basics. Third volume. Great Britain:Academic Press; 2015.
29. Corovic S, Mir LM, Miklavcic D. In vivo muscle electroporation threshold determination: realistic numerical models and in vivo experiments. J Membr Biol 2012;245:509–20.
30. Collins MA, An J, Peller D, Bowser R. Total protein is an effective loading control for cerebrospinal fluid western blots. J Neurosci Methods 2015;251:72–82.
31. Ferguson RE, Carroll HP, Harris A, Maher ER, Selby PJ, Banks RE. Housekeeping proteins: a preliminary study illustrating some limitations as useful references in protein expression studies. Proteomics 2005;5: 566–71.
32. Howard A, Barley NF, Legon S, Walters JR. Plasma-membrane calcium-pump isoforms in human and rat liver. Biochem J 1994;303(Pt 1): 275–9.
33. Talarico EF Jr, Kennedy BG, Marfurt CF, Loeffler KU, Mangini NJ. Expression and immunolocalization of plasma membrane calcium ATPase isoforms in human corneal epithelium. Mol Vis 2005;11:169–78.
34. Zielichowska A, Daczewska M, Saczko J, Michel O, Kulbacka J. Applications of calcium electroporation to effective apoptosis induction in fibrosarcoma cells and stimulation of normal muscle cells. Bioelectrochemistry 2016;109:70–8.
35. Frandsen SK, McNeil AK, Novak I, McNeil PL, Gehl J. Difference in membrane repair capacity between cancer cell lines and a normal cell line. J Membr Biol 2016;249:569–76.
36. Levine ZA, Vernier PT. Calcium and phosphatidylserine inhibit lipid electropore formation and reduce pore lifetime. J Membr Biol 2012;245:599–610.
37. Gehlert S, Bloch W, Suhr F. Ca2+-dependent regulations and signaling in skeletal muscle: from electro-mechanical coupling to adaptation. Int J Mol Sci 2015;16:1066–95.
38. Guerini D. The significance of the isoforms of plasma membrane calcium ATPase. Cell Tissue Res 1998;292:191–97.
39. Livingstone M, Atas E, Meller A, Sonenberg N. Mechanisms governing the control of mRNA translation. Phys Biol 2010;7:021001.
40. Agerholm-Larsen B, Iversen HK, Ibsen P, Moller JM, Mahmood F, Jensen KS, et al. Preclinical validation of electrochemotherapy as an effective treatment for brain tumors. Cancer Res 2011;71:3753–62.
41. Fini M, Salamanna F, Parrilli A, Martini L, Cadossi M, Maglio M, et al. Electrochemotherapy is effective in the treatment of rat bone metastases. Clin Exp Metastasis 2013;30:1033–45.
42. Forde PF, Sadadcharam M, Bourke MG, Conway TA, Guerin SR, de Kruijf M, et al. Preclinical evaluation of an endoscopic electroporation system. Endoscopy 2016;48:477–83.
43. Granata V, Fusco R, Piccirillo M, Palaia R, Petrillo A, Lastoria S, et al. Electrochemotherapy in locally advanced pancreatic cancer: preliminary results. Int J Surg 2015;18:230–6.
44. Davalos RV, Bhonsle S, Neal RE II. Implications and considerations of thermal effects when applying irreversible electroporation tissue ablation therapy. Prostate 2015;75:1114–8.
45. Neal RE II, Garcia PA, Kavnoudias H, Rosenfeldt F, McLean CA, Earl V, et al. In vivo irreversible electroporation kidney ablation: experimentally correlated numerical models. IEEE Trans Biomed Eng 2015;62: 561–9.
46. Neal RE II, Millar JL, Kavnoudias H, Royce P, Rosenfeldt F, Pham A, et al. In vivo characterization and numerical simulation of prostate properties for non-thermal irreversible electroporation ablation. Prostate 2014;74: 458–68.
47. Beebe SJ, Chen X, Liu JA, Schoenbach KH. Nanosecond pulsed electric field ablation of hepatocellular carcinoma. Conf Proc IEEE Eng Med Biol Soc 2011;2011:6861–65.
48. Pakhomova ON, Gregory B, Semenov I, Pakhomov AG. Calcium-mediated pore expansion and cell death following nanoelectroporation. Biochim Biophys Acta 2014;1838:2547–54.
49. Schoenbach KH, Pakhomov AG, Semenov I, Xiao S, Pakhomova ON, Ibey BL. Ion transport into cells exposed to monopolar and bipolar nanosecond pulses. Bioelectrochemistry 2015;103: 44–51.
50. Falk H, Forde PF, Bay ML, Mangalanathan UM, Hojman P, Soden DM, et al. Calcium electroporation induces tumor eradication, long-lasting immunity and cytokine responses in the CT26 colon cancer mouse model. Oncoimmunology 2017;6:e1301332.